Your session is about to expire
← Back to Search
Stem Cell Therapy for Traumatic Brain Injury
Study Summary
This trialundefined
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a head injury without an open wound.I have a known history of neurological issues.I am on medication for seizures.I have recently been treated for a serious infection.I am between 18 and 55 years old.I can speak English or Spanish.I am HIV positive.I do not have low blood pressure or need medicine to maintain my blood pressure at screening.I have lung bruises shown on an X-ray and low oxygen levels due to an injury.I have a spinal cord injury confirmed by imaging or doctor's exam.I can legally consent and undergo a procedure within 48 hours of my injury.My kidney function is reduced with a creatinine level over 1.5 mg/dL.Your Glasgow Coma Score (GCS) is between 3 and 8, which is a measure of how alert you are.I can get consent and undergo a procedure within 48 hours of my injury.I have a severe injury to an organ in my abdomen or pelvis confirmed by imaging.I have a mental health condition that may affect cognitive or behavioral assessments.I have an unstable pelvic fracture that makes bone marrow procedures risky.I am not willing to come back for follow-up visits.My liver isn't working properly (high enzyme levels or bilirubin).I have a history of cancer.
- Group 1: Autologous BMMNC Infusion
- Group 2: Placebo Infusion
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Would I qualify to be a subject in this research?
"This trial is for 55 patients with brain injuries aged 18 to 55. Most notably, applicants must meet the following criteria: Adults 18 to 55 years of age on the day of injury, Non-penetrating closed head trauma., Ability to obtain legally authorized representative consent for participation and complete the BMMNC/Sham harvest and cell/placebo infusion within 48 hours of the initial injury., Glasgow Coma Score between (GCS) between 3 and 8, (best un-medicated post-resuscitation score during screening)."
Can new patients still join this clinical trial?
"According to information on clinicaltrials.gov, this study is not looking for any more patients at the moment. The trial was originally posted on November 21st, 2016 and was last edited on August 1st, 2022. There are other 945 trials that are currently enrolling participants if you're interested in taking part in a clinical trial."
Does the FDA give its stamp of approval to Autologous BMMNC Infusion?
"While Phase 2 trials don't offer much data on efficacy, the available evidence suggests that Autologous BMMNC Infusion is safe."
Are people aged 45 or older being recruited for this trial?
"This study is looking for participants who are younger than 55 and have already reached the age of majority."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger